Radiotherapy for lung cancer that has spread
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether giving radiotherapy to the main lung tumor, along with the usual medicines (like chemotherapy or immunotherapy), can help people with stage IV lung cancer. The goal is to see if adding this treatment helps control the cancer and improves how long patients live.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer that has spread to other parts of the body (stage IV).
- Your cancer does not have certain gene changes (EGFR, ALK, ROS1) that would allow you to take a targeted pill.
- You have not had chest radiation recently (in the past 6 months).
- You have not had another cancer in the last 2 years, except for some early-stage skin cancers or other very early cancers that are cured.
- You do not have active lung inflammation (pneumonitis) or scarring (fibrosis) that requires strong steroid treatment.
- You do not have an autoimmune disease that needed treatment in the past year, unless it's just hormone replacement therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether giving focused radiation therapy to the main lung tumor, in addition to standard treatments like targeted therapy or chemo-immunotherapy, can help people with advanced lung cancer that has spread to many places. The goal is to see if adding this radiation can improve outcomes without causing too many side effects.
This trial tests whether adding a high, focused dose of radiation to the usual first treatment (chemo and/or immunotherapy) can help people with non-small cell lung cancer that has spread to a limited number of spots (up to 5). The goal is to see if this approach improves how well the treatment works.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial tests whether adding radiotherapy to immunotherapy and chemotherapy can help people whose lung cancer has spread to the liver and who have already tried standard treatments. It aims to see if this combination is safe and works better at shrinking tumors.
This trial is for people with advanced non-small cell lung cancer whose tumors responded well to initial chemo-immunotherapy. Instead of giving full chest radiation, doctors will only target the main tumor to see if it can prevent regrowth with fewer side effects.
This trial explores whether combining radiation therapy with immunotherapy can trigger an immune response that shrinks tumors throughout the body (abscopal effect) in people with non-small cell lung cancer that has spread to 3 to 6 other sites. It tests different patterns of these treatments to see which works best.
Hear when a new Carcinoma, Non-Small-Cell Lung (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.